Development of a Multimodal AI Model to Predict the Efficacy of Photodynamic Therapy for Local Residual or Recurrent Lesions Following Chemoradiotherapy or Radiotherapy for Esophageal Cancer
Digestive Endoscopy · 2026
DOI: 10.1111/den.70307 ↗At a glance
Journal article in Digestive Endoscopy, 2026. Written by Keiichiro Nakajo and 9 co-authors. Institution: Division of Science and Technology for Endoscopy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan. Major MEDLINE topics: Photochemotherapy, Esophageal Neoplasms, Neoplasm Recurrence, Local, Chemoradiotherapy. 29 references.
Abstract (original language)
Objectives
Approximately 12%–40% of patients with esophageal cancer develop local residual or recurrent lesions after chemoradiotherapy (CRT) or radiotherapy (RT). Photodynamic therapy (PDT) is a minimally invasive, organ‐preserving alternative; however, therapeutic response is not guaranteed. We developed an artificial intelligence (AI) model to predict PDT efficacy.
Methods
We retrospectively analyzed 177 patients who underwent PDT after CRT/RT at the National Cancer Center Hospital East between August 2006 and December 2024. Clinical data and pre‐PDT endoscopic images obtained within 1 month were collected. Local image features extracted via oriented FAST and rotated BRIEF were integrated with clinical information to build a multimodal support vector machine for binary classification. Model performance was evaluated on an independent test set and compared with that of three endoscopists.
Results
The AI model was trained on 145 cases, achieving an accuracy, recall, precision, and F1 score, and area under the receiver operating characteristic curve of 0.813, 0.833, 0.833, 0.833, and 0.897, respectively in the test cohort of 32 cases. The AI model showed numerically higher accuracy, recall, precision, and F1 score than the endoscopists (0.531, 0.636, 0.389, and 0.483, respectively).
Conclusions
A multimodal AI model integrating clinical data and endoscopic images can accurately predict PDT efficacy after CRT or RT. This approach may help optimize treatment strategies and individualize patient management.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Science and Technology for Endoscopy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
- NEXT Medical Device Innovation Center, National Cancer Center Hospital East, Chiba, Japan.
- Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Kashiwa, Japan.
- Division of Endoscopy, Saitama Cancer Center, Saitama, Japan.
- Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan.
- Department of Advanced Physics and Engineering, Tokyo University of Agriculture and Technology, Graduate School of Engineering, Tokyo, Japan.
ORCID profiles: Keiichiro Nakajo, Haruto Hirose, Atsuki Imai, Hiroshi Takemura, Tomonori Yano
Cite
APA
Nakajo, K., Sasagawa, Y., Tomino, T., Hirose, H., Imai, A., Endo, M., Yamashita, H., Yamamoto, M., Takemura, H., & Yano, T. (2026). Development of a Multimodal AI Model to Predict the Efficacy of Photodynamic Therapy for Local Residual or Recurrent Lesions Following Chemoradiotherapy or Radiotherapy for Esophageal Cancer. Digestive Endoscopy. https://doi.org/10.1111/den.70307
Vancouver
Nakajo K, Sasagawa Y, Tomino T, Hirose H, Imai A, Endo M, et al. Development of a Multimodal AI Model to Predict the Efficacy of Photodynamic Therapy for Local Residual or Recurrent Lesions Following Chemoradiotherapy or Radiotherapy for Esophageal Cancer. Digestive Endoscopy. 2026. doi:10.1111/den.70307
BibTeX
@article{Nakajo2026,
author = {Nakajo, Keiichiro and Sasagawa, Yu and Tomino, Takuro and Hirose, Haruto and Imai, Atsuki and Endo, Minami and Yamashita, Hiroki and Yamamoto, Masataka and Takemura, Hiroshi and Yano, Tomonori},
title = {Development of a Multimodal AI Model to Predict the Efficacy of Photodynamic Therapy for Local Residual or Recurrent Lesions Following Chemoradiotherapy or Radiotherapy for Esophageal Cancer},
journal = {Digestive Endoscopy},
year = {2026},
doi = {10.1111/den.70307}
}
EUVIMED